ClinicalTrials.gov
ClinicalTrials.gov Menu

Physical Activity in Patients With Systemic Lupus Erythematosus (LESPA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00985803
Recruitment Status : Unknown
Verified October 2009 by Federal University of São Paulo.
Recruitment status was:  Enrolling by invitation
First Posted : September 28, 2009
Last Update Posted : October 8, 2009
Sponsor:
Information provided by:
Federal University of São Paulo

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

The purpose of this study is to check the improvement in quality of life in patients with systemic lupus incorporated into a routine of physical activity.

Randomized controlled blinded trial, 63 patients aged 42.9 ± 14.4 and diagnosis of systemic lupus erythematosus (SLE) according to the criteria of the College American Rheumatology, 1997. After randomization patients were allocated into 3 groups, control group (CG) (n = 21), training cardiovascular (CT) (n = 20), resistance training (RT) (n = 22), performing 12 weeks of intervention with a frequency of three times weeks and were evaluated at two different times (T0 and T12). As primary outcome quality of life was assessed by the inventory Generic Assessment of quality of life by the Medical Outcomes Study 36 -- Healthy ItemShort Form Survey (SF36) and as secondary outcomes functional capacity evaluation of pain symptoms (visual scale analogue pain [VAS]), intensity of symptoms of depression (Beck Depression Inventory [BDI]), index of disease activity (Systemic Lupus Disease Activity Inventory Erythmatodud [SLEDAI]), capacity aerobic (walking test of 12 minutes [T12]), subjective perception effort (subjective scale of Borg [Borg]), limb muscle strength lower (analog dynamometer [strength]), electrical activity member lower (surface electromyography [EMG]), amount of products (inventory amount of Medicines).


Condition or disease Intervention/treatment Phase
Systemic Lupus Erythematosus Other: Physical Activity: Cardio training (CT) Other: Physical Activity: Endurance exercise training (ET) Phase 1

  Show Detailed Description

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Comparison of Cardiovascular Training Versus Resistance Training In Patients With Systemic Lupus Erythematosus: Controlled Randomized Clinical Trial
Study Start Date : November 2009
Primary Completion Date : November 2009
Study Completion Date : March 2010

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
No Intervention: Group Control
Experimental: Endurance Other: Physical Activity: Endurance exercise training (ET)

The experimental group of resistance training will carry out the training with 8 kinds of training session with 12 reps with that load will vary according to the 1 RM test.

The composition of the training session is 10 minutes of heating and stretching, 40 minutes of cardiovascular training and 10 minutes of cooling.
Experimental: Cardiovascular Other: Physical Activity: Cardio training (CT)

The experimental group of resistance training will carry out the training with 8 kinds of training session with 12 reps with that load will vary according to the 1 RM test.

The composition of the training session is 10 minutes of heating and stretching, 40 minutes of cardiovascular training and 10 minutes of cooling.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Life quality [ Time Frame: 12 weeks ]

Secondary Outcome Measures :
  1. Pain [ Time Frame: 12 weeks ]
  2. Strength [ Time Frame: 12 weeks ]
  3. Electromyography [ Time Frame: 12 weeks ]
  4. Aerobic capacity [ Time Frame: 12 weeks ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • (American College of Rheumatology). It is necessary to have the presence of room between the elevens criteria for diagnosis:

    • malar erythema
    • discoid lesions
    • photosensitivity
    • oral or nasal ulcers
    • arthritis
    • serositis
    • renal
    • neurological
    • hematological
    • immunological changes
    • antinuclear antibodies.

Exclusion Criteria:

  • Patients with hemoglobin level 10gm/dL, sequelae of cardiovascular events, - Respiratory diseases (pulmonary hypertension, pulmonary fibrosis
  • Bronchitis, asthma, emphysema)
  • Heart failure (NYHA> II)
  • History of myocardial ischemia or heart
  • Blood pressure> 100 mm Hg.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00985803


Locations
Brazil
AmbulatoAmbulatory Specialty Interlagos - General Hospital Grajaú - Association Congregation Santa Catarina
São Paulo, Brazil, 04671300
Sponsors and Collaborators
Federal University of São Paulo
Investigators
Principal Investigator: Marcelo I Abrahão University Federal of São Paulo
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Marcelo Ismael Abrahão, Federal University of São Paulo
ClinicalTrials.gov Identifier: NCT00985803     History of Changes
Other Study ID Numbers: MAbrahao
First Posted: September 28, 2009    Key Record Dates
Last Update Posted: October 8, 2009
Last Verified: October 2009

Keywords provided by Federal University of São Paulo:
Systemic Lupus Erythematosus
Activity Physical
Activity Disease,trials randomized

Additional relevant MeSH terms:
Lupus Erythematosus, Systemic
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases